Google on Monday announced a set of new security features in Chrome, following the company's addition of agentic artificial intelligence (AI) capabilities to the web browser. To that end, the tech ...

The UK’s National Cyber Security Centre (NCSC) has highlighted a potentially dangerous misunderstanding surrounding emergent prompt injection attacks against generative artificial intelligence (GenAI) ...

Security experts working for British intelligence warned on Monday that large language models may never be fully protected from “prompt injection,” a growing type of cyber threat that manipulates AI ...

A command injection vulnerability in Array Networks AG Series secure access gateways has been exploited in the wild since August 2025, according to an alert issued by JPCERT/CC this week. The ...

Many injectable peptides are unregulated and have not been reviewed for safety by the FDA. Users have reported side effects such as injection site reactions, fatigue, headaches, and gastrointestinal ...

An attempt to delay Tennessee's next execution over concerns about its new lethal injection protocol was shot down in late November, two weeks before Harold Wayne Nichols is scheduled to be put to ...

Forbes contributors publish independent expert analyses and insights. AI researcher working with the UN and others to drive social change. Dec 01, 2025, 07:08am EST Hacker. A man in a hoodie with a ...

Microsoft plans to enhance the security of the Entra ID authentication system against external script injection attacks starting in mid-to-late October 2026. This update will implement a strengthened ...

People with severe asthma sometimes rely on daily steroid pills, which raise the risk of diabetes, infections and bone problems. Now, a study supports the idea that a monthly antibody injection is a ...

Pill versions of the obesity drugs now taken only as injections are on the way. We look at the science behind the pills and if they might be more affordable and accessible than the shots. Drugs like ...

FDA approved EYLEA HD for macular edema post-RVO with up to 8-week dosing after initial monthly doses. Phase 3 QUASAR trial showed non-inferior visual acuity gains with EYLEA HD compared to EYLEA.